Skip to main navigation Skip to search Skip to main content

Reports Outline Engineered T-Cells Findings from National Cancer Institute (NCI) (Adoptive Cellular Therapy With Autologous Tumor-infiltrating Lymphocytes and T-cell Receptor- Engineered T Cells Targeting Common P53 Neoantigens In Human Solid ...)

Press/Media

Period25 May 2023

Media coverage

1

Media coverage